SEC Form 4 · accession 0001225208-18-007725
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Luc M Lemercier
Officer — CVP, EMEA, Canada, Latin Amer
Period of report
Apr 11, 2018
Accepted (ET)
Apr 12, 2018 · 7:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 11, 2018 | M | 5,633 | $44.615 | A | 44,473 | D | |
| Common Stock | Apr 11, 2018 | S | 5,633 | $139.42 | D | 38,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $44.615 | Apr 11, 2018 | M | 5,633 | D | May 12, 2012 | May 11, 2018 | Common Stock | 5,633 | 5,634 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2018.
- F2This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.